0001193125-25-272468
SEC filingRevenue slightly declined QoQ due to product mix shift, while operating expenses decreased significantly, narrowing net loss.
For the three months ended September 30, 2025, total revenue was $53.7 million, a decrease of $0.3 million or 1% compared to $54.0 million in the same period of 2024. Product revenue decreased by $0.2 million to $51.1 million, driven by a change in product mix and average selling price, partially offset by an increase in volume. Contract revenue decreased by $0.1 million to $2.6 million.
Cost of goods sold decreased by $0.6 million to $32.2 million, resulting in a gross profit of $21.5 million, up slightly from $21.2 million in the prior year. Gross margin improved to 40.1% from 39.3%.
Operating expenses decreased significantly by $11.9 million or 11% to $92.0 million. Research and development expense fell by $8.0 million or 17% to $38.0 million, primarily due to a $7.8 million reduction in personnel costs from restructuring initiatives in August 2024 and May 2025. Selling, general and administrative expense remained relatively flat at $20.8 million. Restructuring costs were $1.0 million for the 2025 Restructuring Plan, compared to $4.3 million in the prior year for a separate plan.
Other expense, net improved to $2.7 million from $5.0 million, driven by a $4.5 million favorable swing in the change in fair value of contingent considerations, partially offset by higher interest expense of $2.2 million due to the 2029 Notes. Net loss improved to $41.0 million from $51.3 million in the prior year.
The company reports two revenue segments: Product Revenue and Contract Revenue. Product Revenue, which constitutes 95% of total revenue, remained nearly flat year-over-year at $51.1 million. The slight decline was attributed to product mix and pricing changes, offset by higher volumes. Contract Revenue, representing 5% of total revenue, decreased 3% to $2.6 million, reflecting the wind-down of a large multi-year non-recurring engineering project that began in early 2022.
Management expects research and development expense and selling, general and administrative expense to stabilize over time. The company is pursuing the divestiture of its 34.38% equity interest in Wuxi, which accounted for 43% of consolidated revenue in Q3 2025, for approximately $135 million. The transaction is subject to regulatory approvals and shareholder approval by United Faith. The company believes its current sources of liquidity, including cash and cash equivalents of $171.2 million as of September 30, 2025, will be sufficient to meet its liquidity needs for at least the next 12 months. The company also has $59.8 million available for future issuances under its ATM Agreement.
As of September 30, 2025, indie Semiconductor held $160.9M in cash and cash equivalents, a significant decline from $274.2M at December 31, 2024. Total debt stood at $353.5M (carrying value), including $128.0M in 4.50% Convertible Senior Notes due 2027 (after repurchasing $30M principal during the period) and $210.9M in 3.50% Convertible Senior Notes due 2029. The company also had restricted cash of $10.3M under a secured credit facility. Shareholders' equity was $392.9M, down from $445.4M due to cumulative losses.
No significant purchase commitments were disclosed beyond routine royalty agreements and contingent earn-out liabilities. Royalty expense totaled $1.5M for the nine months ended September 30, 2025. The company has $7.3M in contingent consideration related to the emotion3D acquisition, payable in cash or stock upon achieving revenue milestones. Additionally, $2.97M in holdbacks from the emotion3D acquisition are classified in current and long-term liabilities.
No share repurchases occurred during the nine months ended September 30, 2025; the remaining authorization totals $42.6M. No dividends were declared or paid. The company actively managed its debt: it repurchased $30M aggregate principal of its 2027 Notes at a discount, recognizing a $2.6M gain on extinguishment. Proceeds from new debt were $2.8M, primarily from the Wells Fargo revolving line of credit. Capital expenditures totaled $12.6M, mainly for production tooling and construction in progress.
The company operates as a single reportable segment. Revenue is geographically diversified: Greater China contributed 43% of revenue ($68.4M), Europe 21% ($33.9M), United States 16% ($26.2M), South Korea 8% ($12.1M), and other regions 12%. The September 2025 acquisition of emotion3D (Austria-based) is expected to further expand European operations. The company's one-segment structure means all costs and operating losses are consolidated, with an operating loss of $120.3M for the nine months.
The company reported a net loss of $119.5 million, but operating cash outflow of $42.8 million was significantly better due to large non-cash charges: share-based compensation of $50.6 million, depreciation and amortization of $30.4 million, and asset impairment of $3.2 million. Working capital provided a net positive of $3.9 million, driven by a $4.9 million decrease in inventory and a $845,000 decrease in receivables, partially offset by a $9.8 million decrease in accounts payable.
Capital expenditures of $12.6 million were flat year-over-year, representing a capex intensity of about 29% of operating cash outflow (not meaningful given negative CFO). Free cash flow was not explicitly stated; however, with CFO of -$42.8M and capex of $12.6M, implied FCF would be -$55.4M.
Notable items include a $4.9 million gain from change in fair value of contingent considerations, a $2.6 million gain on debt extinguishment, and $3.2 million in restructuring-related asset impairment. The company also repurchased $26.8 million of debt obligations. There were no share repurchases or dividends during the period.